Steroid receptors and response to endocrine treatment and chemotherapy of advanced breast cancer

The remission rates after endocrine and cytostatic treatment were determined in 192 female patients with advanced breast cancer depending on the estrogen, progesterone, and androgen receptor content and on the diseasedominant site.